BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38913304)

  • 1. The Importance of Monitoring Non-clonal Chromosome Aberrations (NCCAs) in Cancer Research.
    Heng E; Thanedar S; Heng HH
    Methods Mol Biol; 2024; 2825():79-111. PubMed ID: 38913304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why it is crucial to analyze non clonal chromosome aberrations or NCCAs?
    Heng HH; Regan SM; Liu G; Ye CJ
    Mol Cytogenet; 2016; 9():15. PubMed ID: 26877768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The New Era of Cancer Cytogenetics and Cytogenomics.
    Ye JC; Heng HH
    Methods Mol Biol; 2024; 2825():3-37. PubMed ID: 38913301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal and non-clonal chromosome aberrations and genome variation and aberration.
    Heng HH; Liu G; Bremer S; Ye KJ; Stevens J; Ye CJ
    Genome; 2006 Mar; 49(3):195-204. PubMed ID: 16604101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tracking Karyotype Changes in Treatment-Induced Drug-Resistant Evolution.
    Ye JC; Heng HH
    Methods Mol Biol; 2024; 2825():263-280. PubMed ID: 38913315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges and Opportunities for Clinical Cytogenetics in the 21st Century.
    Heng E; Thanedar S; Heng HH
    Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micronuclei and Genome Chaos: Changing the System Inheritance.
    Ye CJ; Sharpe Z; Alemara S; Mackenzie S; Liu G; Abdallah B; Horne S; Regan S; Heng HH
    Genes (Basel); 2019 May; 10(5):. PubMed ID: 31086101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stochastic cancer progression driven by non-clonal chromosome aberrations.
    Heng HH; Stevens JB; Liu G; Bremer SW; Ye KJ; Reddy PV; Wu GS; Wang YA; Tainsky MA; Ye CJ
    J Cell Physiol; 2006 Aug; 208(2):461-72. PubMed ID: 16688757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer progression by non-clonal chromosome aberrations.
    Heng HH; Bremer SW; Stevens J; Ye KJ; Miller F; Liu G; Ye CJ
    J Cell Biochem; 2006 Aug; 98(6):1424-35. PubMed ID: 16676347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-phased evolution: Genome chaos-mediated information creation and maintenance.
    Heng J; Heng HH
    Prog Biophys Mol Biol; 2021 Oct; 165():29-42. PubMed ID: 33992670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What Is Karyotype Coding and Why Is Genomic Topology Important for Cancer and Evolution?
    Ye CJ; Stilgenbauer L; Moy A; Liu G; Heng HH
    Front Genet; 2019; 10():1082. PubMed ID: 31737054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome based cell population heterogeneity promotes tumorigenicity: the evolutionary mechanism of cancer.
    Ye CJ; Stevens JB; Liu G; Bremer SW; Jaiswal AS; Ye KJ; Lin MF; Lawrenson L; Lancaster WD; Kurkinen M; Liao JD; Gairola CG; Shekhar MP; Narayan S; Miller FR; Heng HH
    J Cell Physiol; 2009 May; 219(2):288-300. PubMed ID: 19115235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Step-wise and punctuated genome evolution drive phenotype changes of tumor cells.
    Stepanenko A; Andreieva S; Korets K; Mykytenko D; Huleyuk N; Vassetzky Y; Kavsan V
    Mutat Res; 2015 Jan; 771():56-69. PubMed ID: 25771981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dynamics of cancer chromosomes and genomes.
    Ye CJ; Liu G; Bremer SW; Heng HH
    Cytogenet Genome Res; 2007; 118(2-4):237-46. PubMed ID: 18000376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Karyotype heterogeneity and unclassified chromosomal abnormalities.
    Heng HH; Liu G; Stevens JB; Abdallah BY; Horne SD; Ye KJ; Bremer SW; Chowdhury SK; Ye CJ
    Cytogenet Genome Res; 2013; 139(3):144-57. PubMed ID: 23571381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Insights in the Cytogenetic Practice: Karyotypic Chaos, Non-Clonal Chromosomal Alterations and Chromosomal Instability in Human Cancer and Therapy Response.
    Rangel N; Forero-Castro M; Rondón-Lagos M
    Genes (Basel); 2017 Jun; 8(6):. PubMed ID: 28587191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome chaos: survival strategy during crisis.
    Liu G; Stevens JB; Horne SD; Abdallah BY; Ye KJ; Bremer SW; Ye CJ; Chen DJ; Heng HH
    Cell Cycle; 2014; 13(4):528-37. PubMed ID: 24299711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome Recognition.
    Wan TS; Hui EK; Ng MH
    Methods Mol Biol; 2017; 1541():67-74. PubMed ID: 27910015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Origins and Consequences of Chromosomal Instability: From Cellular Adaptation to Genome Chaos-Mediated System Survival.
    Ye CJ; Sharpe Z; Heng HH
    Genes (Basel); 2020 Sep; 11(10):. PubMed ID: 33008067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding aneuploidy in cancer through the lens of system inheritance, fuzzy inheritance and emergence of new genome systems.
    Ye CJ; Regan S; Liu G; Alemara S; Heng HH
    Mol Cytogenet; 2018; 11():31. PubMed ID: 29760781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.